REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,416 | +10.2% | 1,883 | -1.9% | 0.00% | 0.0% |
| Q2 2023 | $271,603 | +8.4% | 1,920 | +29.0% | 0.00% | 0.0% |
| Q1 2023 | $250,520 | +106504.3% | 1,488 | +7.4% | 0.00% | 0.0% |
| Q4 2022 | $235 | -99.9% | 1,386 | -5.8% | 0.00% | -25.0% |
| Q3 2022 | $275,000 | +18.5% | 1,471 | +2.9% | 0.00% | 0.0% |
| Q2 2022 | $232,000 | -21.6% | 1,430 | -9.1% | 0.00% | 0.0% |
| Q1 2022 | $296,000 | -32.0% | 1,574 | -4.1% | 0.00% | -20.0% |
| Q4 2021 | $435,000 | +9.0% | 1,641 | +18.9% | 0.01% | 0.0% |
| Q3 2021 | $399,000 | +51.1% | 1,380 | +4.2% | 0.01% | +66.7% |
| Q2 2021 | $264,000 | +0.8% | 1,325 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $262,000 | +6.9% | 1,347 | +5.5% | 0.00% | 0.0% |
| Q4 2020 | $245,000 | – | 1,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |